Table 3.
Overall Survival Rate of Patients According to HKLC And BCLC Staging System
| All HCC patients (N=79) | Viral-associated HCC patients (N=55) | |||||||
|---|---|---|---|---|---|---|---|---|
| 1-year survival | 2-year survival | 5-year survival | P-value | 1-year survival | 2-year survival | 5-year survival | P-value | |
| HKLC | ||||||||
| - Stage I | 100.00% | 89.06% | 81.64% | <0.001 | 100.00% | 92.31% | 92.31% | 0.016 |
| - Stage IIa | 82.22% | 74.00% | 61.66% | 76.15% | 65.27% | 65.27% | ||
| - Stage IIb | 76.29% | 54.42% | 54.42% | 66.67% | 66.67% | 66.67% | ||
| BCLC | ||||||||
| - Stage 0 | 100.00% | 80.00% | 60.00% | 0.053 | 100.00% | 75.00% | 75.00% | 0.153 |
| - Stage A | 86.79% | 82.23% | 75.90% | 93.85% | 86.38% | 86.38% | ||
| - Stage B | 76.15% | 26.65% | 26.65% | 85.71% | 64.29% | 64.29% | ||